Nucleostemin expression in breast cancer is a marker of more aggressive phenotype and unfavorable patients’ outcome: A STROBE-compliant article

por Sami, Manal M., Hachim, Mahmood Y., Hachim, Ibrahim Y., Elbarkouky, Ahmed H., López-Ozuna, Vanessa M.
Publicado 2019